{
    "Trade/Device Name(s)": [
        "Atellica\u00ae IM Total hCG (ThCG)"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Inc.",
    "510(k) Number": "K192790",
    "Predicate Device Reference 510(k) Number(s)": [
        "K172322"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DHA"
    ],
    "Summary Letter Date": "October 30, 2019",
    "Summary Letter Received Date": "September 30, 2019",
    "Submission Date": "September 27, 2019",
    "Regulation Number(s)": [
        "21 CFR 862.1155"
    ],
    "Regulation Name(s)": [
        "Human chorionic gonadotropin (HCG) test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine"
    ],
    "Analyte(s)": [
        "Human chorionic gonadotropin (hCG)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "Lithium heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Atellica\u00ae IM Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Sandwich immunoassay",
        "Direct chemiluminescent"
    ],
    "Methodologies": [
        "Immunoassay",
        "Chemiluminescence"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Ancillary reagent pack"
    ],
    "Document Summary": "FDA 510(k) summary for Atellica IM Total hCG (ThCG) quantitative immunoassay for hCG on serum and plasma using Atellica IM Analyzer",
    "Indications for Use Summary": "Quantitative determination of human chorionic gonadotropin (hCG) in human serum or plasma (EDTA or lithium heparin) as an aid in the early detection of pregnancy using Atellica IM Analyzer",
    "fda_folder": "Clinical Chemistry"
}